How have IRTC and VKTX total returns compared?

Over the past 5 years, IRTC delivered 12.95% and VKTX delivered 37.36% annualized total return. Past performance doesn't predict future results.

iRhythm Technologies, Inc. (IRTC) vs Viking Therapeutics, Inc. (VKTX)

A side-by-side comparison of iRhythm Technologies, Inc. and Viking Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IRTC

iRhythm Technologies, Inc.

$3.53B

$107.46HealthcareDelayed quote: Oct 6, 2026, 3:25 PM EDT

VKTX

Viking Therapeutics, Inc.

$3.31B

$28.41HealthcareDelayed quote: Oct 6, 2026, 3:25 PM EDT

Total return — IRTC vs VKTX

growth of $100 · dividends reinvested · last 10y

IRTC +318.8% (+15.4%/yr)VKTX +2446.1% (+38.2%/yr)VKTX compounded faster over this window

Log scale — wide-divergence pair

IRTC VKTX

IRTC vs VKTX: by the numbers

•IRTC is the larger company ($3.53B vs $3.31B market cap).
•Both run net losses; VKTX's is the smaller (0.00% vs -1.69% net margin).

Metrics side by side

Valuation

Metric	IRTC	VKTX
P/S ratio	4.28	N/A
P/B ratio	18.99	8.12
EV / EBITDA	286.97	N/A
FCF yield	1.10%	N/A

Profitability

Metric	IRTC	VKTX
Gross margin	71.45%	0.00%
Operating margin	-1.17%	0.00%
Net margin	-1.69%	0.00%
ROE	-7.50%	-130.98%
ROIC	-1.07%	-135.85%

Growth (annualized)

Metric	IRTC	VKTX
Revenue CAGR (5Y)	21.93%	N/A
Total return CAGR (5Y)	12.95%	37.36%

Frequently asked

How have IRTC and VKTX total returns compared?: Over the past 5 years, IRTC delivered 12.95% and VKTX delivered 37.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IRTC analysis Full VKTX analysis Interactive comparison tool

Dig into the metrics

iRhythm Technologies ROE Viking Therapeutics ROE iRhythm Technologies operating margin Viking Therapeutics operating margin iRhythm Technologies revenue growth Viking Therapeutics revenue growth iRhythm Technologies free cash flow Viking Therapeutics free cash flow

iRhythm Technologies & Viking Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.